<h1>Lytus Technologies Moves to OTC Markets as LYTHF, Reports 24% Revenue Growth and Secures $100 Million Financing</h1> Lytus Technologies has transitioned to trading on OTC Markets under symbol LYTHF, redirecting resources toward platform services expansion, HealthTech innovation, and digital infrastructure. The company reported 24% year-over-year revenue increase to $12.01 million and achieved profitability in the first half of FY2025. Through its subsidiary, Lytus HealthTech, the company is developing an AI-powered patient care ecosystem for underserved regions in India. The company secured up to $100 million in strategic financing with $6 million already drawn. Lytus remains open to relisting on a major exchange when market conditions improve while continuing to focus on digital streaming, HealthTech, fintech, and AI solutions.